Legal News

FDA explains expectations for drugmakers' data retention

FDA explains expectations for drugmakers' data retention
Published on: 13 December 2018
Published by: Law360
  • FDA explains expectations for drugmakers' data retention
  • What is this development about?

Article summary

Law360, New York: The U.S. Food and Drug Administration (FDA) answered drugmakers’ questions about how to maintain data from drug tests and the manufacturing floor, following an uptick in violations of federal information retention standards. or take a trial to read the full analysis.

Popular documents